Biotech Strategic Asset Factory

At VihoLabs, our Biotech Strategic Asset Factory accelerates product development by up to 40% using AI and proprietary systems. This creates a unique pipeline protected by strong intellectual property.

Discover Our Platform

Transforming Global Health

Our innovative approach combines cutting-edge science with strategic business development

Our Biotech Strategic Asset Factory

Founded by industry veterans, VihoLabs is building a strategic asset factory with proprietary products across high-growth therapeutic verticals.

Speed to Market

VihoLabs uses AI to speed up product development by up to 40%.

Scientific Precision

AI-driven methods for higher success rates and targeted outcomes.

Competitive Edge

Protected by trade secrets, brands, and IP, creating a value monopoly.

Discover Our Verticals

Core Expertise Areas

Our multidisciplinary team brings together specialized knowledge to drive our Biotech Strategic Asset Factory

Our success is built on a foundation of diverse expertise across critical domains. Each area of specialization contributes to our ability to accelerate product development and deliver innovative solutions to global health challenges.

Scientific Leadership

Deep pharmaceutical industry experience with expertise in drug development and innovation. Our scientific team brings decades of research knowledge and has led multiple successful product launches across various therapeutic areas.

Business Development

Extensive international business development experience with a focus on global strategic partnerships. Our team has a proven track record in market expansion and specializes in healthcare and life sciences commercialization.

Regulatory Excellence

Comprehensive regulatory affairs experience with deep understanding of global compliance requirements. Our regulatory experts navigate complex health policy landscapes and ensure adherence to international standards across all markets.

Biotech Strategic Asset Factory Technology

Our proprietary platform that synchronizes multiple therapeutic pathways for enhanced efficacy and faster results

Revolutionary Synchronization Platform

SynchroAxis is our breakthrough technology that coordinates multiple biological pathways at once, creating effects that improve results while reducing side effects.

Multi-Pathway Synchronization

Coordinates gut-brain, metabolic, and immune pathways for full therapeutic impact.

AI-Driven Optimization

Machine learning algorithms that refine treatments based on real-world results.

Enhanced Safety Profile

Reduces side effects through precise modulation and targeted delivery.

87%

Efficacy Improvement

3.2x

Faster Results

62%

Fewer Side Effects

Request Technology Brief

High-Growth Therapeutic Verticals

Our innovative platform enables targeted solutions across multiple high-value therapeutic areas

Obesity & Weight Control

Addressing the global obesity pandemic with innovative, non-invasive solutions.

$48B+

Market Size

31%

CAGR

Longevity & Active Aging

Extending healthspan through metabolic optimization and active aging solutions.

$159B

Projected Market

7.4%

CAGR

Supportive Oncology

Improving quality of life for cancer patients through innovative supportive care.

$69B

Market Size

35M

Cases by 2050

Gut-Brain Disorders

Addressing hidden epidemics through gut-brain axis modulation.

581M

People Affected

31%

CAGR

Fibromyalgia & Pain

Enhancing daily function for those with chronic pain conditions.

$5B+

Market Size

5%

Global Population

Sports & Physiotherapy

Boosting performance and recovery for athletes and physiotherapy patients.

$112B

Combined Market

8.2%

Sports CAGR

Investment Opportunity

Join us in revolutionizing biotechnology and creating value monopolies

Connect With Our Team

Discover how VihoLabs is shaping the future of biotech. Reach out to learn more about investment opportunities.

Full Name* Work Email* Phone (with country code)* Company* Role / Title* Country* Select your country SpainPortugalFranceItaly GermanyUnited KingdomUnited StatesMexico Saudi ArabiaUAEKenyaNigeria BrazilOther Message*

Leave this field empty

Anti-spam: 5 + 2 = ? *

I agree to be contacted regarding VihoLabs' investor materials and confirm the information provided is accurate.

Request Investor Deck